Cognex Corporation (NASDAQ: CGNX) — FY2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014; includes unaudited fourth-quarter results. Cognex supplies machine-vision and identification products for factory automation, semiconductor/electronics equipment, and continuous-surface inspection. The Modular Vision Systems Division (MVSD) represented about 82% of revenue.
Financial performance
| Metric | FY2014 | FY2013 |
|---|---|---|
| Revenue | $486.3 million | $353.9 million |
| Gross profit / margin | $365.3 million / 75% | $269.8 million / 76% |
| Operating income / margin | $143.7 million / 30% | $86.4 million / 24% |
| Net income / margin | $121.5 million / 25% | $73.6 million / 21% |
| Diluted EPS | $1.36 | $0.83 |
| Cash from operations | $156.0 million | $95.5 million |
| Capital expenditures | $20.9 million | $9.6 million |
Revenue rose 37%, with factory-automation sales up 41%, semiconductor/electronics equipment sales up 14%, and surface-inspection sales up 29%. Product revenue was $451.1 million; service revenue was $35.2 million. Gross margin eased because the largest customer arrangement carried lower margins, and new-product introduction costs and inventory charges increased. Operating income grew 66% despite higher operating expenses.
Fourth quarter: Revenue was $117.2 million, operating income $31.1 million, and net income $26.6 million. Revenue fell from $169.4 million in Q3 2014, largely reflecting lower sales to the major factory-automation customer.
Liquidity, debt, and capital allocation
Year-end cash, cash equivalents, and investments totaled $547.0 million, including $489.3 million in debt securities; working capital was $183.9 million, versus $271.0 million a year earlier. Cognex reported no long-term debt and said it did not anticipate needing debt financing in the near future. Operating cash flow less capital expenditures was approximately $135.0 million. Capital spending included the purchase of its Cork, Ireland distribution-center building. The company repurchased $59.7 million of stock in 2014; no dividends were paid in 2014.
Material changes and management commentary
- Revenue from one customer, direct and indirect, was approximately $70 million in 2014, or 14% of total revenue; it was approximately $10 million in 2013. Excluding this customer, factory-automation revenue grew 20%.
- Service gross margin declined to 44% from 55%, primarily due to relatively low-margin on-site support for that customer. MVSD gross margin fell to 78% from 80%; SISD gross margin improved to 55% from 54%.
- RD&E expense increased 25% to $59.9 million. Management expects significant continued investment and targets RD&E spending of 10%–15% of revenue, with the percentage affected by revenue levels.
- Backlog, including deferred revenue, was $62.1 million at year-end, up from $49.7 million; management cautioned that backlog is not necessarily indicative of future revenue and orders may be canceled.
Outlook, risks, contingencies, and unusual items
The filing provides no specific numerical revenue or earnings guidance. Management highlighted continued product development and expansion of factory automation and logistics identification markets, while noting limited visibility in the cyclical semiconductor/electronics equipment market. A weaker euro into early 2015 was identified as a potential headwind to reported revenue.
- Customer concentration is a key risk: loss or reduced purchases by the major customer could materially affect results; its pricing and support arrangement also weighed on margins and required inventory spending ahead of collections.
- Other principal exposures include global manufacturing conditions, consumer-electronics and automotive spending, international operations and foreign exchange, competition, product transitions, and reliance on a third-party manufacturer in Indonesia and certain single-source components.
- Patent litigation: Cognex obtained a $2.6 million jury award and an injunction against Microscan over one patent, but the award and infringement judgment were under appeal. Separately, Microscan alleged that Cognex products infringed another patent; the case was pending, and the company stated an adverse outcome could materially affect its financial position, liquidity, or results.
- The 2014 effective tax rate was 18%, including favorable discrete tax adjustments. Potential releases of tax reserves could reduce tax expense by approximately $0.9–$1.0 million over the following 12 months.
- Foreign-currency translation reduced other comprehensive income by $9.4 million in 2014. Investment securities had a net unrealized loss of $0.1 million, which management considered temporary; no investment or goodwill impairment was recorded.
Grant Thornton issued unqualified opinions on the financial statements and internal control over financial reporting.
Investor facts to verify
- Whether the major customer’s purchases and associated lower-margin support arrangement persist, and how the customer concentration changes.
- Whether growth excluding that customer continues across factory automation, logistics identification, and surface inspection.
- Effects of euro and yen movements, new-product costs, and inventory reserves on revenue and gross margins.
- Developments and potential financial exposure in both Microscan patent matters.
- Cash generation, investment portfolio liquidity and value, tax-reserve outcomes, and the pace of stock repurchases.